Thomas F. Ryan Jr., Director at REPLIGEN CORP (RGEN), sold 2,000 shares at $198.48 ($396K) on 2022-03-01, disclosed to the SEC on 2022-03-02.
Open-market sale of $396k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $197.58 | 1,000 | $198K | 49.9% |
| 2 | $198.48 | 1,000 | $198K | 50.1% |
| Total | $198.03 avg | 2,000 | $396K | 100% |
| Filing → |
| RGEN | SELL | 2021-03-04 | $205K | — | Filing → |
| RGEN | SELL | 2020-11-13 | $351K | — | Filing → |
| RGEN | SELL | 2020-08-04 | $940K | — | Filing → |